Aier(SZ:300015)2015-01-19 16:00Financial Performance - The company expects a net profit attributable to shareholders of approximately 301.72 million yuan, representing a year-on-year increase of 35%-45% compared to 223.50 million yuan in the previous year[3] - The total net profit for the reporting period is estimated at 324.07 million yuan[3] - The impact of non-recurring gains and losses on net profit is estimated to be around 5 million yuan[7] - The performance forecast has not been audited by a registered accountant[4] - The specific financial data will be detailed in the 2014 annual report[7] - The performance forecast indicates a positive trend in the company's operational results[3] Revenue Growth - The growth in medical service revenue is attributed to the increasing scale and brand effect, particularly in cataract surgeries and optical services[5] - The number of profitable hospitals is continuously increasing, with significant revenue growth from hospitals still in the cultivation phase[5] Investment and Risk Awareness - The company emphasizes the importance of rational investment and risk awareness for investors[7] Operational Focus - The company is focused on maintaining steady growth in its medical services[5]